Clinical trial
Irinotecan and Temozolomide in Treating Young Patients With Recurrent…
NCT00311584 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00311584 |
|---|---|
| Title | Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma |
| Official title | A Phase II Study of Irinotecan + Temozolomide in Children With Recurrent Neuroblastoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, temozolomide |
| Enrollment | 59 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Dec 1, 2013 |
| First posted | Apr 6, 2006 |
| Last update posted | Sep 30, 2014 |
| Countries | Australia, Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: